These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 857684)

  • 41. Quality and cost improvement of healthcare via complementary measurement and diagnosis of patient general health outcome using electronic health record data: research rationale and design.
    Stusser RJ; Dickey RA
    J Med Syst; 2013 Dec; 37(6):9977. PubMed ID: 24046235
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of functional status and quality of life in claudication.
    Mays RJ; Casserly IP; Kohrt WM; Ho PM; Hiatt WR; Nehler MR; Regensteiner JG
    J Vasc Surg; 2011 May; 53(5):1410-21. PubMed ID: 21334172
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quality of life evaluation in wounds: validation of the Freiburg Life Quality Assessment-wound module, a disease-specific instrument.
    Augustin M; Herberger K; Rustenbach SJ; Schäfer I; Zschocke I; Blome C
    Int Wound J; 2010 Dec; 7(6):493-501. PubMed ID: 20880326
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Therapeutic benefits in dermatological therapy. Evaluation of therapy from the physician's und patient's perspective in psoriasis and atopic dermatitis].
    Zschocke I; Hammelmann U; Augustin M
    Hautarzt; 2005 Sep; 56(9):839-42, 844-6. PubMed ID: 15700156
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quality-of-life considerations in the treatment of asthma.
    Juniper EF
    Pharmacoeconomics; 1995 Aug; 8(2):123-38. PubMed ID: 10155607
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quality-of-life instruments for severe chronic mental illness. Implications for pharmacotherapy.
    Becker M
    Pharmacoeconomics; 1995 Mar; 7(3):229-37. PubMed ID: 10155312
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Health-related quality of life assessment and the pharmaceutical industry.
    Revicki DA; Rothman M; Luce B
    Pharmacoeconomics; 1992 Jun; 1(6):394-408. PubMed ID: 10147021
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quality of life instruments in the evaluation of new drugs.
    Jaeschke R; Guyatt GH; Cook D
    Pharmacoeconomics; 1992 Feb; 1(2):84-94. PubMed ID: 10146938
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of antihypertensive treatment on the quality of later years.
    James MA; Potter JF
    Drugs Aging; 1993; 3(1):26-39. PubMed ID: 8453183
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Measuring functional disability in the older population.
    German PS
    Am J Public Health; 1981 Nov; 71(11):1197-9. PubMed ID: 7294259
    [No Abstract]   [Full Text] [Related]  

  • 51. A quantitative approach to perceived health status: a validation study.
    Hunt SM; McKenna SP; McEwen J; Backett EM; Williams J; Papp E
    J Epidemiol Community Health; 1980 Dec; 34(4):281-6. PubMed ID: 7241028
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Toward clinical applications of health status measures: sensitivity of scales to clinically important changes.
    Deyo RA; Inui TS
    Health Serv Res; 1984 Aug; 19(3):275-89. PubMed ID: 6746293
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The dimensions of health outcomes: a cross-validated examination of health status measurement.
    Brown JH; Kazis LE; Spitz PW; Gertman P; Fries JF; Meenan RF
    Am J Public Health; 1984 Feb; 74(2):159-61. PubMed ID: 6691531
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pitfalls in measuring the health status of Mexican Americans: comparative validity of the English and Spanish Sickness Impact Profile.
    Deyo RA
    Am J Public Health; 1984 Jun; 74(6):569-73. PubMed ID: 6232861
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The impact of exercise upon medical costs.
    Shephard RJ
    Sports Med; 1985; 2(2):133-43. PubMed ID: 3923589
    [No Abstract]   [Full Text] [Related]  

  • 56. The Functional Status Questionnaire: reliability and validity when used in primary care.
    Jette AM; Davies AR; Cleary PD; Calkins DR; Rubenstein LV; Fink A; Kosecoff J; Young RT; Brook RH; Delbanco TL
    J Gen Intern Med; 1986; 1(3):143-9. PubMed ID: 3772582
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quality of life during antihypertensive therapy: techniques for clinical assessment and evaluation.
    Testa MA
    Br J Clin Pharmacol; 1987; 23 Suppl 1(Suppl 1):9S-13S. PubMed ID: 3580259
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Measuring quality of life in clinical trials: a taxonomy and review.
    Guyatt GH; Veldhuyzen Van Zanten SJ; Feeny DH; Patrick DL
    CMAJ; 1989 Jun; 140(12):1441-8. PubMed ID: 2655856
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quality of life in the first 100 days after suspected acute myocardial infarction--a suitable trial endpoint?
    Rawles J; Light J; Watt M
    J Epidemiol Community Health; 1992 Dec; 46(6):612-6. PubMed ID: 1494078
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Insensitive health statistics and the dilemma of the HSAs.
    Elinson J
    Am J Public Health; 1977 May; 67(5):417-8. PubMed ID: 855886
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.